The impact of bone metastases on pain: post-hoc analysis of a phase III study of denosumab in men with non-metastatic Castration-Resistant Prostate Cancer (CRPC)
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Date issued
2013Journal title
BJU INTERNATIONAL
Type of content
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)